Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark.
Int J Obes (Lond). 2023 Jul;47(7):554-563. doi: 10.1038/s41366-023-01299-0. Epub 2023 Apr 7.
A bidirectional relationship exists between adipose tissue metabolism and iron regulation. Total body fat, fat distribution and exercise influence iron status and components of the iron-regulatory pathway, including hepcidin and erythroferrone. Conversely, whole body and tissue iron stores associate with fat mass and distribution and glucose and lipid metabolism in adipose tissue, liver, and muscle. Manipulation of the iron-regulatory proteins erythroferrone and erythropoietin affects glucose and lipid metabolism. Several lines of evidence suggest that iron accumulation and metabolism may play a role in the development of metabolic diseases including obesity, type 2 diabetes, hyperlipidaemia and non-alcoholic fatty liver disease. In this review we summarise the current understanding of the relationship between iron homoeostasis and metabolic disease.
脂肪组织代谢与铁调节之间存在双向关系。总体脂肪、脂肪分布和运动影响铁状态和铁调节途径的组成部分,包括铁调素和红细胞生成素。相反,全身和组织铁储存与脂肪质量和分布以及脂肪组织、肝脏和肌肉中的葡萄糖和脂质代谢相关。铁调节蛋白红细胞生成素和促红细胞生成素的操作会影响葡萄糖和脂质代谢。有几条证据表明,铁积累和代谢可能在代谢疾病的发展中起作用,包括肥胖、2 型糖尿病、高脂血症和非酒精性脂肪肝疾病。在这篇综述中,我们总结了目前对铁动态平衡与代谢疾病之间关系的理解。